Treating asthma as a neuroelectrical disorder

Inflammation and Allergy - Drug Targets

Volumn 9, Issue 2, 2010, Pages 130-134

  Hoang, Ba X ^a   Shaw, D Graeme ^b   Pham, Phuong ^c   Levine, Stephen A ^a  

^a Allergy Research Group   (United States)

^b University of Southern California ^*  (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Asthma; Bronchoconstriction; Glutamate receptors; Inflammation; Ion channels

Indexed keywords

GLUTAMATE RECEPTOR; VOLTAGE GATED SODIUM CHANNEL; GLUTAMIC ACID; SODIUM CHANNEL;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHOSPASM; BRONCHUS REACTIVITY; INFLAMMATION; MEMBRANE DEPOLARIZATION; BRONCHOCONSTRICTION; DRUG EFFECTS; HUMAN; LUNG; MEMBRANE POTENTIAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ASTHMA; BRONCHOCONSTRICTION; GLUTAMIC ACID; HUMANS; LUNG; MEMBRANE POTENTIALS; RECEPTORS, GLUTAMATE; SODIUM CHANNELS;

EID: 77953783333     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152810791292827     Document Type: Article

References (40)

1. Braman, S.S. The global burden of asthma. Chest, 2006, 130(1 Suppl), 4S-12S.
2. Nouri-Aria, K.T., Durham S.R. Regulatory T cells and allergic disease. Inflamm. Allergy Drug Targets, 2008, 7(4), 237-52.
3. Fang, C.; Corrigan, C.J.; Ying, S. The treatment targets of asthma: from laboratory to clinic. Inflamm. Allergy Drug Targets, 2008, 7(2), 119-28.
4. Hoang, B.X.; Levine, S.A.; Graeme, S. D.; Pham, P.; Hoang, C. Bronchial epilepsy or broncho-pulmonary hyper-excitability as a model of asthma pathogenesis. Med. Hypotheses, 2006, 67(5), 1042-51.
5. Butler, C.A.; Heaney, L.G. Neurogenic inflammation and asthma. Inflamm. Allergy Drug Targets, 2007, 6(2), 127-32.
6. Groneberg, D.A.; Quarcoo, D.; Frossard, N.; Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy, 2004, 59(11), 1139-52.
7. Hoang, B.X.; Shaw, D.G.; Levine, S.; Hoang, C.; Pham, P. New approach in asthma treatment using excitatory modulator. Phytother. Res., 2007, 21(6), 554-7.
8. Faffe, D.S.; Asthma: where is it going? Braz. J. Med. Biol. Res., 2008, 41(9), 739-49.
9. Nakashima, Y.; Sugiyama, S.; Shindoh, J.; Taki, F.; Takagi, K.; Satake T.; Ozawa, T. Effects of sodium channel blockers on electrical field stimulation-induced guinea-pig tracheal smooth muscle contraction. Arch. Int. Pharmacodyn. Ther., 1990, 306,130-8.
10. Shinjoh, M.; Nakaki, T.; Otsuka, Y.; Sasakawa, N.; Kato, R. Vascular smooth muscle contraction induced by Na+ channel activators, veratridine and batrachotoxin. Eur. J. Pharmacol., 1991, 205(2), 199-202.
11. Mall, M.A.; Harkema, J.R.; Trojanek, J.B.; Treis, D.; Livraghi, A.; Schubert, S.; Zhou, Z.; Kreda, S.M.; Tilley, S.L.; Hudson, E.J.; O'Neal, W.K.; Boucher, R.C. Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice. Am. J. Respir. Crit. Care Med., 2008, 177(7), 730-42.
12. Ouyang, W.; Herold, K.F.; Hemmings, H.C. Jr. Comparative effects of halogenated inhaled anesthetics on voltage-gated Na+ channel function. Anesthesiology, 2009, 110(3), 582-90.
13. Lauretti, G.R. Mechanisms of analgesia of intravenous lidocaine. Rev. Bras. Anestesiol., 2008, 58(3), 280-6.
14. Adamzik, M.; Groeben, H.; Farahani, R.; Lehmann, N.; Peters, J. Intravenous lidocaine after tracheal intubation mitigates bronchoconstriction in patients with asthma. Anesth. Analg., 2007, 104(1), 168-72.
15. Hunt, L.W.; Frigas, E.; Butterfield, J.H.; Kita, H.; Blomgren, J.; Dunnette, S.L.; Offord, K.P.; Gleich, G.J. Treatment of asthma with nebulized lidocaine: a randomized, placebo-controlled study. J. Allergy Clin. Immunol., 2004, 113(5), 853-9.
16. Siqueira, R.A.; Costa, J.C.; Cordeiro, R.S.; Serra, M.F.; e Silva, P.M.; Martins, M.A. Local anaesthetic medication for the treatment of asthma. Mem. Inst. Oswaldo Cruz., 2005, 100 Suppl 1, 161-5.
17. Toda, N.; Toda, H.; Hatano, Y. Anesthetic modulation of immune reactions mediated by nitric oxide. J. Anesth., 2008, 22(2), 155-62.
18. Yregard, L.; Cassuto, J.; Tarnow, P.; Nilsson, U. Influence of local anaesthetics on inflammatory activity postburn. Burns, 2003, 29(4), 335-341.
19. Cassuto, J.; Sinclair, R.; Bonderovic, M. Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta. Anaesthesiol. Scand., 2006, 50(3), 265-82.
20. Lomia, M.; Tchelidze, T.; Pruidze, M. Bronchial asthma as neurogenic paroxysmal inflammatory disease: a randomized trial with carbamazepine. Respir. Med., 2006, 100(11),1988-96.
21. Jain, S.; Jain, K.C. Effect of phenytoin sodium in the management of poorly controlled bronchial asthma at a rural health center in Phalodi, Rajasthan, India. J. Asthma, 1991, 28(3), 201-11.
22. Dickman, K.G.; Youssef, J.G.; Mathew, S.M.; Said, S.I. Ionotropic glutamate receptors in lungs and airways: molecular basis for glutamate toxicity. Am. J. Respir. Cell Mol. Biol., 2004, 30(2), 139-44.
23. Byrnes, K.R.; Loane, D.J.; Faden, A.I. Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics, 2009, 6(1), 94-107.
24. Hoang, B.X.; Levin, S.A.; Pham, P.; Shaw, D.G. Hypothesis of the cause and development of neoplasms. Eur. J. Cancer Prev., 2007, 16(1), 55-61.
25. Olney, J.W. Excitotoxic amino acids and neuropsychiatric disorders. Annu. Rev. Pharmacol. Toxicol., 1990, 30, 47-71.
26. Beal, M.F. Mechanisms of excitotoxicity in neurologic diseases. FASEB J., 1992, 6(15), 3338-44.
27. Lipton, S.A.; Gendelman, H.E. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med., 1995, 332(14), 934-40.
28. Yankner, B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron, 1996, 16(5), 921-32.
29. Xu, L.; Sun, J.; Lu, R.; Ji, Q.; Xu, J.G. Effect of glutamate on inflammatory responses of intestine and brain after focal cerebral ischemia. World J. Gastroenterol., 2005, 11(5), 733-6.
30. Oprica, M.; Eriksson, C.; Schultzberg. M. Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system. J. Cell Mol. Med., 2003, 7(2), 127-40.
31. Said, S.I.; Berisha, H.I.; Pakbaz, H. Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA, 1996, 93(10), 4688-92.
32. Chen, C.J.; Kono, H.; Golenbock, D.; Reed, G.; Akira, S.; Roc,k K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med., 2007, 13(7), 851-6.
33. Said, S.I.; Berisha, H.I.; Pakbaz, H. N-methyl-D-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide. Neuroscience, 1995, 65(4), 943-46.
34. Said, S.I. Glutamate receptors and asthmatic airway disease. Trends Pharmacol Sci, 1999, 20(4), 132-4.
35. Said, S.I.; Dey, R.D.; Dickman, K. Glutamate signalling in the lung. Trends Pharmacol Sci, 2001, 22(7), 344-5.
36. Agrawal, A.; Agrawal, K.P.; Ram, A.; Sondhi, A.; Chhabra, S.K.; Gangal, S.V.; Mehta, D. Basis of rise in intracellular sodium in airway hyperresponsiveness and asthma. Lung, 2005, 183(6), 375-87.
37. Giuliani, D.; Giaroni, C.; Zanetti, E.; Canciani, L.; Borroni, P.; Lecchini, S.; Frigo, G. Involvement of glutamate receptors of the NMDA type in the modulation of acetylcholine and glutamate overflow from the guinea pig ileum during in vitro hypoxia and hypoglycaemia. Neurochem. Int.; 2006, 48(3), 191-200.
38. Haxhiu, M.A.; Chavez, J.C.; Pichiule, P.; Erokwu, B.; Dreshaj, I.A. The excitatory amino acid glutamate mediates reflexly increased tracheal blood flow and airway submucosal gland secretion. Brain Res.; 2000, 883(1), 77-86.
39. Chen, H.S.; Lipton, S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem.; 2006, 97(6), 1611-26.
40. Holgate, S.; Bisgaard, H.; Bjermer, L.; Haahtela, T.; Haughney, J.; Horne, R.; McIvor, A.; Palkonen, S.; Price, D.B.; Thomas, M.; Valovirta, E.; Wahn, U. The Brussels Declaration: the need for change in asthma management. Eur. Respir. J.; 2008, 32(6), 1433-42.